Alosetron Hydrochloride

盐酸阿洛司琼

Report date: 2023/04/21 17:59:50
NME

Base Information

Drug NameAlosetron Hydrochloride
Drug Alias NameAlosetronum阿洛斯琼Alosetron阿洛司琼Lotronex +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsIrritable Bowel Syndrome
Global Approved IndicationsIrritable Bowel Syndrome
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2000/02/09
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaDiscontinued
Originator CompaniesPrometheus Inc
China Registration ClassN/A

Develop Information

Active CompaniesLegacy Pharma Inc
Inactive CompaniesGlaxosmithkline PlcHuapont Life Sciences Co Ltd
Active IndicationsIrritable Bowel Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeA03AE01
Related LinksWikipediaDrugBankKEGG